[Poster] Variable Definitions of “Unresectable” Stage III NSCLC Among Lung Cancer Specialists

Presented at the IASCLC 2020 North America Conference on Lung Cancer, October 16 to October 17, 2020.

Authors

Percy P. Lee¹, Leigh Boehmer², Matthew Smeltzer³, Brendon M. Stiles⁴

¹Department of Radiation Oncology, University of Texas MD Anderson Cancer Center; ²Association of Community Cancer Centers; ³Division of Epidemiology, Biostatistics, and Environmental Health, University of Memphis School of Public Health; ⁴Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York-Presbyterian Hospital

Background

Stage III non-small cell lung cancer (NSCLC) is a heterogeneous disease that often elicits differing opinions regarding what is “unresectable”, depending upon the specialist and the treatment setting. Using survey data, we sought to characterize opinions regarding the resectability of stage III NSCLC.